Becker MD - Search Results

1

Ocular outcome and frequency of neurological manifestations in patients with acute posterior multifocal placoid pigment epitheliopathy (APMPPE).

Thomas BC, Jacobi C, Korporal M, Becker MD, Wildemann B, Mackensen F. Thomas BC, et al. Among authors: becker md. J Ophthalmic Inflamm Infect. 2012 Sep;2(3):125-31. doi: 10.1007/s12348-012-0077-7. Epub 2012 May 11. J Ophthalmic Inflamm Infect. 2012. PMID: 22573398 Free PMC article.

2

Risk of Recurrence of Preexisting Ocular Toxoplasmosis during Pregnancy.

Reich M, Ruppenstein M, Becker MD, Mackensen F. Reich M, et al. Among authors: becker md. Ocul Immunol Inflamm. 2015 Jun;23(3):240-5. doi: 10.3109/09273948.2014.916306. Epub 2014 May 19. Ocul Immunol Inflamm. 2015. PMID: 24841072

3

Interferon therapy for ocular disease.

Mackensen F, Max R, Becker MD. Mackensen F, et al. Among authors: becker md. Curr Opin Ophthalmol. 2006 Dec;17(6):567-73. doi: 10.1097/ICU.0b013e328010ab35. Curr Opin Ophthalmol. 2006. PMID: 17065927 Review.

4

Interferons and their potential in the treatment of ocular inflammation.

Mackensen F, Max R, Becker MD. Mackensen F, et al. Among authors: becker md. Clin Ophthalmol. 2009;3:559-66. doi: 10.2147/opth.s3308. Epub 2009 Oct 19. Clin Ophthalmol. 2009. PMID: 19898628 Free PMC article.

5

Difficulties of interpreting Borrelia serology in patients with uveitis.

Mackensen F, Zimmermann S, Alle W, Max R, Jakob E, Becker MD, Thiemeyer D. Mackensen F, et al. Among authors: becker md. Ocul Immunol Inflamm. 2011 Aug;19(4):227-31. doi: 10.3109/09273948.2011.568662. Ocul Immunol Inflamm. 2011. PMID: 21770797

6

Time patterns of recurrences and factors predisposing for a higher risk of recurrence of ocular toxoplasmosis.

Reich M, Ruppenstein M, Becker MD, Mackensen F. Reich M, et al. Among authors: becker md. Retina. 2015 Apr;35(4):809-19. doi: 10.1097/IAE.0000000000000361. Retina. 2015. PMID: 25299969

7

Influence of drug therapy on the risk of recurrence of ocular toxoplasmosis.

Reich M, Becker MD, Mackensen F. Reich M, et al. Among authors: becker md. Br J Ophthalmol. 2016 Feb;100(2):195-9. doi: 10.1136/bjophthalmol-2015-306650. Epub 2015 Jul 10. Br J Ophthalmol. 2016. PMID: 26163541

8

Randomized Controlled Study to Evaluate the Efficacy of Adalimumab in Patients with Different Forms of Refractory Uveitis.

Mackensen F, Heinz C, Jakob E, Grewing V, Lorenz HM, Heiligenhaus A, Max R, Becker MD. Mackensen F, et al. Among authors: becker md. Ocul Immunol Inflamm. 2018;26(7):1015-1022. doi: 10.1080/09273948.2017.1411518. Epub 2017 Dec 29. Ocul Immunol Inflamm. 2018. PMID: 29286865 Free article. Clinical Trial.

9

Experiences with rituximab for the treatment of autoimmune diseases with ocular involvement.

Pelegrin L, Jakob E, Schmidt-Bacher A, Schwenger V, Becker M, Max R, Lorenz HM, Mackensen F. Pelegrin L, et al. J Rheumatol. 2014 Jan;41(1):84-90. doi: 10.3899/jrheum.130206. Epub 2013 Nov 15. J Rheumatol. 2014. PMID: 24241484

10

In Vivo Laser Confocal Microscopy Using the HRT-Rostock Cornea Module: Diversity and Diagnostic Implications in Patients with Uveitis.

Lim LL, Xie J, Chua CC, Wong T, Hoang LT, Becker MD, Suhler EB, Rosenbaum JT, Mackensen F. Lim LL, et al. Among authors: becker md. Ocul Immunol Inflamm. 2018;26(6):900-909. doi: 10.1080/09273948.2017.1298818. Epub 2017 May 31. Ocul Immunol Inflamm. 2018. PMID: 28562149

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

118 results

Search Page

Filters